Altamira Therapeutics Ltd. Fair Value Of Acquired Receivables
Altamira Therapeutics Ltd. (CYTOF) had Fair Value Of Acquired Receivables of CHF 572.25 thousand as of 2018-07-17, per its 20-F filed 2023-05-16.
Discontinued › Notes
ifrs-full:FairValueOfAcquiredReceivables · last filed 2023-05-16
- 2018-07-17: Fair Value Of Acquired Receivables 572.25K CHF.
- 2018-01-30: Fair Value Of Acquired Receivables 2.48M CHF.
| Period end | Fair Value Of Acquired Receivables |
|---|---|
| 2018-07-17 | 572.25K CHF 20-F · filed 2023-05-16 |
| 2018-01-30 | 2.48M CHF 20-F · filed 2023-05-16 |